Establishment Labs Holdings Inc
ESTA
Market Cap$1.18B
Close$
$56.38
32% upside
Current Fair Value
32% upsideUndervalued by 32% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.18 Billion |
|---|---|
| Enterprise Value | $1.16 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.03 |
| Beta | 0.75 |
| Outstanding Shares | 29,475,649 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.54 |
|---|---|
| PEG | -48.66 |
| Price to Sales | 8.54 |
| Price to Book Ratio | 42.71 |
| Enterprise Value to Revenue | 6.83 |
| Enterprise Value to EBIT | -16.25 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 1.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Establishment Labs Holdings Inc
521 employees
CEO: Juan Jose Chacon Quiros Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...